Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Argenx Se ADR (ARGX)

Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,039,244
  • Shares Outstanding, K 59,431
  • Annual Sales, $ 1,269 M
  • Annual Income, $ -295,050 K
  • 60-Month Beta 0.64
  • Price/Sales 21.64
  • Price/Cash Flow N/A
  • Price/Book 6.74
Trade ARGX with:

Options Overview Details

View History
  • Implied Volatility 33.58% ( -1.86%)
  • Historical Volatility 40.18%
  • IV Percentile 23%
  • IV Rank 26.27%
  • IV High 60.34% on 12/19/23
  • IV Low 24.05% on 08/30/23
  • Put/Call Vol Ratio 0.81
  • Today's Volume 439
  • Volume Avg (30-Day) 380
  • Put/Call OI Ratio 1.44
  • Today's Open Interest 10,180
  • Open Int (30-Day) 9,021

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.90
  • Number of Estimates 12
  • High Estimate 0.07
  • Low Estimate -1.67
  • Prior Year -1.69
  • Growth Rate Est. (year over year) +46.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
377.47 +24.99%
on 06/17/24
475.33 -0.74%
on 07/12/24
+84.80 (+21.91%)
since 06/14/24
3-Month
352.77 +33.74%
on 05/14/24
475.33 -0.74%
on 07/12/24
+101.12 (+27.28%)
since 04/16/24
52-Week
327.73 +43.96%
on 12/21/23
550.76 -14.34%
on 07/21/23
+92.72 (+24.46%)
since 07/14/23

Most Recent Stories

More News
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond

These five biotech companies could have a lot of room to run.

AMGN : 328.00 (-1.54%)
ARGX : 471.80 (+2.13%)
BGNE : 152.92 (+3.49%)
CRSP : 61.50 (-1.99%)
IMVT : 30.92 (+1.34%)
Carlyle Group, Seadrill rise; PG&E, Argenx fall, Tuesday, 11/28/2023

Stocks that traded heavily or had substantial price changes on Tuesday: Carlyle Group, Seadrill rise; PG&E, Argenx fall

SDRL : 54.08 (-1.35%)
TWLO : 59.80 (-0.30%)
ARGX : 471.80 (+2.13%)
WPC : 58.25 (+0.09%)
PCG : 17.70 (-0.11%)
These 2 Stocks Are Falling in a Fading Rally

It's been a good month, but the stock market's looking tired.

ZS : 199.00 (-2.03%)
ARGX : 471.80 (+2.13%)
Why Immunovant Stock Is Bolting Higher Today

The company may have best-in-class autoimmune disease therapy under its roof.

ARGX : 471.80 (+2.13%)
JNJ : 150.20 (-0.54%)
IMVT : 30.92 (+1.34%)
ROIV : 11.50 (-0.95%)
Argenx's 28% Surge & Promising Product Propel Investor Confidence

Argenx's chart is forming a bullish base after a 28% jump after positive clinical trials. Analysts believe the immunology specialist is an acquisition target.

ARGX : 471.80 (+2.13%)
ABBV : 169.18 (-0.01%)
ABCL : 3.40 (-2.58%)
ALNY : 246.50 (-1.33%)
AMGN : 328.00 (-1.54%)
ANAB : 34.48 (+5.41%)
AZN : 78.47 (-0.15%)
BMY : 41.20 (unch)
INCY : 64.00 (-0.39%)
REGN : 1,094.99 (+1.19%)
VIE : 53.01 (unch)
Is Argenx Stock a Buy Now?

Good news keeps rolling in for the biotech.

ARGX : 471.80 (+2.13%)
Why Shares of Argenx Jumped This Week

The company's lead therapy showed progress in treating an autoimmune disorder.

ARGX : 471.80 (+2.13%)
Why Argenx Stock Is on Fire Today

A major clinical win is boosting the drugmaker's shares today.

ARGX : 471.80 (+2.13%)
You Can't Afford to Miss Monday's 2 Nasdaq Biotech Stock Movers

Big gains are afoot even as the markets prepare for a flat open.

COMP : 4.69 (-1.26%)
$NASX : 18,509.34 (+0.20%)
ARGX : 471.80 (+2.13%)
BBIO : 29.25 (+5.06%)
This Emerging Market Could Be the Next Big Thing in Biotech

Medicines to treat the many symptoms of long COVID are in high demand already.

PRTC : 22.29 (-3.92%)
PFE : 29.31 (-0.64%)
ARGX : 471.80 (+2.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.

See More

Key Turning Points

3rd Resistance Point 492.52
2nd Resistance Point 483.89
1st Resistance Point 477.84
Last Price 471.80
1st Support Level 463.16
2nd Support Level 454.53
3rd Support Level 448.48

See More

52-Week High 550.76
Last Price 471.80
Fibonacci 61.8% 465.56
Fibonacci 50% 439.24
Fibonacci 38.2% 412.92
52-Week Low 327.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar